New findings from a major trial offer a clearer, more nuanced view of how GLP-1 medications may influence the course of ...

WHO’s new guidance supports Ozempic-class GLP-1 drugs for obesity treatment, but only alongside behavioural therapy and long-term care, stressing safety concerns, high costs, and the urgent need for ...

The World Health Organization is officially backing popular weight-loss drugs like Ozempic and Wegovy. The WHO published new ...

We knew that GLP-1 drugs like Ozempic and Wegovy did more than just help control type 2 diabetes and aid weight loss, but the ...

This is read by an automated voice. Please report any issues or inconsistencies here. Ozempic, Zepbound, and Wegovy are now household names. And as these GLP-1 medications have exploded in popularity, ...

Scientists are testing whether GLP-1 drugs can help to cut cravings for cigarettes, alcohol and opioids — as well as food.

The popularity of GLP-1 weight-loss medications continues to soar—and their uptake is helping to push down obesity rates on a national scale—but a safe, evidence-based way off the drugs isn’t yet in ...

Some experts cited the case of Slentrol, an older weight loss drug for dogs made by Pfizer’s animal health division (which ...

Popular drugs credited with shrinking waistlines and controlling blood sugar may also take the edge off alcohol’s buzz, according to a new study. Researchers at Virginia Tech's Fralin Biomedical ...

Novo Nordisk NVO shares fell roughly 4% in pre-market trading today after U.S. President Donald Trump signaled potential steep price cuts for the company’s blockbuster GLP-1 RA drugs during a White ...

Akeso, Inc. (9926.HK) ('Akeso' or the 'Company') announced the successful inclusion of all five of the Company's self-developed innovative drugs into the updated National Reimbursement Drug List (NRDL ...